Table 3

Immunoexpression of the different markers in MBC, myofibroblastomas phyllodes tumor, and PASH

Antibody

MBC (%)

Myofibroblastoma (%)

Phyllodes Tumor (%)

PASH (%)


SNAIL

34/34 (100%)

4/4 (100%)

14/14 (100%)

7/8 (87.5%)

EGFR

34/34 (100%)

0/4 (0%)

13/14 (92.9%)

8/8 (100%)

OSCAR

29/34 (85.3%)

0/4 (0%)

2/14 (14.3%)

0/8 (0%)

WS-KER

26/34 (76.5%)

0/4 (0%)

0/14 (0%)

0/8 (0%)

P63

23/34 (56.7%)

0/4 (0%)

0/14 (0%)

0/8 (0%)


MBC = metaplastic breast carcinoma

PASH = pseudoangiomatous stromal hyperplasia

Nassar et al. Diagnostic Pathology 2010 5:76   doi:10.1186/1746-1596-5-76

Open Data